- Home
- AAMI vs SNDX Comparison
AAMI vs SNDX Comparison
Compare AAMI & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAMI
- SNDX
- Stock Information
- Founded
- AAMI 1980
- SNDX 2005
- Country
- AAMI United States
- SNDX United States
- Employees
- AAMI N/A
- SNDX N/A
- Industry
- AAMI Investment Managers
- SNDX Biotechnology: Pharmaceutical Preparations
- Sector
- AAMI Finance
- SNDX Health Care
- Exchange
- AAMI Nasdaq
- SNDX Nasdaq
- Market Cap
- AAMI 964.3M
- SNDX 1.1B
- IPO Year
- AAMI N/A
- SNDX 2016
- Fundamental
- Price
- AAMI $25.14
- SNDX $13.80
- Analyst Decision
- AAMI
- SNDX Strong Buy
- Analyst Count
- AAMI 0
- SNDX 10
- Target Price
- AAMI N/A
- SNDX $36.90
- AVG Volume (30 Days)
- AAMI 223.6K
- SNDX 2.9M
- Earning Date
- AAMI 01-30-2025
- SNDX 02-25-2025
- Dividend Yield
- AAMI 0.16%
- SNDX N/A
- EPS Growth
- AAMI N/A
- SNDX N/A
- EPS
- AAMI 1.65
- SNDX N/A
- Revenue
- AAMI $469,000,000.00
- SNDX $16,000,000.00
- Revenue This Year
- AAMI N/A
- SNDX N/A
- Revenue Next Year
- AAMI N/A
- SNDX N/A
- P/E Ratio
- AAMI $15.20
- SNDX N/A
- Revenue Growth
- AAMI 12.17
- SNDX N/A
- 52 Week Low
- AAMI $18.59
- SNDX $12.40
- 52 Week High
- AAMI $31.52
- SNDX $25.34
- Technical
- Relative Strength Index (RSI)
- AAMI N/A
- SNDX 44.24
- Support Level
- AAMI N/A
- SNDX $12.40
- Resistance Level
- AAMI N/A
- SNDX $14.65
- Average True Range (ATR)
- AAMI 0.00
- SNDX 0.59
- MACD
- AAMI 0.00
- SNDX 0.24
- Stochastic Oscillator
- AAMI 0.00
- SNDX 62.22
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.